Patel, N.R.

Approaches for Clinical Supply Modelling and Simulation

Creating Value With Financially Adaptive Clinical Trials

Impact of Phase 2b Strategies on Optimization of Drug Development Programs

Drug Development and the Cost of Capital

Dynamically Optimizing Budget Allocation for Phase 3 Drug Development Portfolios Incorporating Uncertainty in the Pipeline

Methodological Extensions of Phase 2 Trial Designs Based on Program-level Considerations: Further Development of a Case Study in Neuropathic Pain